+987.9%
MRNA vs SN
+156.5%
+831.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | SN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | +4.1% | +9.0% | +12.4% |
| 7D | +20.6% | +10.6% | +10.0% | +18.7% |
| 30D | +27.1% | +20.0% | +7.1% | +23.6% |
| 3M | +353.4% | +30.4% | +323.0% | +325.6% |
| 6M | +446.3% | +91.0% | +355.3% | +346.9% |
| YTD | +776.2% | +95.9% | +680.2% | +582.0% |
| 1Y | +987.9% | +158.9% | +829.0% | +668.1% |
| All | +987.9% | +156.5% | +831.5% | +668.1% |
Cumulative growth
Daily Returns
Daily percentage return beside SN.
Daily Out/Under-Performance
Portfolio return minus SN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × SN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded SN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling